CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Francis Richard D President and CEO | Sale 10b5-1 | −6,450 | $15.56 | $100K | 245,333 |
| 2025-03-03 | Weiss Amir Chief Accounting Officer | Option exercise | +5,179 | 10,358 | ||
| 2025-03-03 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −5,179 | 10,359 | ||
| 2025-03-03 | Sabag Mark See "Remarks" | Option exercise | +24,900 | 229,864 | ||
| 2025-03-03 | Sabag Mark See "Remarks" | Option exercise · Restricted Share Units | −24,900 | 49,801 | ||
| 2025-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise 10b5-1 | +62,250 | 62,250 | ||
| 2025-03-03 | Daniell Richard Exec. VP, European Commercial | Sale 10b5-1 | −49,314 | $16.19 | $798K | 12,936 |
| 2025-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units 10b5-1 | −62,250 | 124,503 | ||
| 2025-03-03 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +24,900 | 24,900 | ||
| 2025-03-03 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −19,726 | $16.19 | $319K | 5,174 |
| 2025-03-03 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −24,900 | 49,801 | ||
| 2025-03-03 | Francis Richard D President and CEO | Option exercise 10b5-1 | +67,231 | 276,675 | ||
| 2025-03-03 | Francis Richard D President and CEO | Sale 10b5-1 | −24,892 | $16.19 | $403K | 251,783 |
| 2025-03-03 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −67,231 | 134,462 | ||
| 2025-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise 10b5-1 | +49,800 | 197,741 | ||
| 2025-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units 10b5-1 | −49,800 | 99,602 | ||
| 2025-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale 10b5-1 | −55,750 | $16.21 | $903K | 147,941 |
| 2025-02-18 | Francis Richard D President and CEO | Sale 10b5-1 | −75,506 | $16.95 | $1.3M | 209,444 |
| 2025-02-15 | Francis Richard D President and CEO | Option exercise 10b5-1 | +161,655 | 284,950 | ||
| 2025-02-15 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −161,655 | 161,656 |
Page 18 of 76 · 1,517 trades